Meet the lab’s two new members

Our lab is growing! We are excited to introduce two new members who have joined the Lochmüller lab this winter.

Daniel O’Neil

Daniel holds a BSc in Biochemistry from the University of Ottawa. During his undergraduate studies, he worked with Dr. Alexandre Blais’s laboratory where he studied the role of the Six1 transcription factor in adult satellite cell proliferation. Subsequently, he completed his MSc in Neuroscience at the University of Ottawa in Dr. Ruth Slack’s laboratory. His thesis examined the role of the activator E2f transcription factors, crucial regulators of cell cycle progression, in adult neural stem cell quiescence and activation.

Daniel looks forward to applying his accumulated technical knowledge to support ongoing research projects in Dr. Lochmüller’s lab.

 

Catherine Choueiri

Catherine recently graduated with an HBSc degree in Biology from Western University in October 2020. After completing her final year, she worked as a research assistant and laboratory manager in Dr. Kathleen Hill’s lab. In her role, she contributed to projects relevant to environmental mutagenesis, mouse SNP genotyping, and the use of genomic signatures for disease screening. Under Kathleen Hill’s supervision, Catherine also completed a teaching fellowship at Western, during which she helped to redesign the Principles of Human Genetics course for online delivery.

In January 2021, Catherine began her Master’s program in Cellular and Molecular Medicine with a specialization in Human and Molecular Genetics. She is working under the supervision of Dr. Lochmüller to create a zebrafish model for riboflavin transporter deficiency to be used in therapeutic screening.

 

 

Neuromuscular junction and animal models

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...